Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Mar;79(7-8):1249–1254. doi: 10.1038/sj.bjc.6690200

Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers

J Fujimoto 1, H Sakaguchi 1, R Hirose 1, S Ichigo 1, T Tamaya 1
PMCID: PMC2362259  PMID: 10098767

Abstract

Angiogenesis contributes to the growth and secondary spreading of solid tumours. Platelet-derived endothelial cell growth factor (PD-ECGF) is identified as such an angiogenic factor. In the present study, the prognosis of the patients with high PD-ECGF uterine cervical cancers was worse than those with low PD-ECGF cancers, and PD-ECGF expression correlated with cellular proliferation and with vascular density and venous invasion in uterine cervical cancers. Therefore, PD-ECGF might contribute to the growth of uterine cervical cancers via angiogenesis related to vascular spreading. Furthermore, PD-ECGF and its mRNA had a wide range and were highly expressed in uterine cervical cancers, especially squamous cell carcinoma, regardless of clinical stage. Therefore, PD-ECGF in uterine cervical cancers might play a role of basic angiogenesis in all processes of advancing of uterine cervical cancers. This indicates that 5′-deoxy-5-fluorouridine might be highly effective in squamous cell carcinoma of the cervix, which possesses a high activity of thymidine phosphorylase to convert 5′-deoxy-5-fluorouridine to 5-fluorouracil, and that some angiogenic inhibitors of new capillary formation might be effective in the inhibition of tumour growth and spreading associated with angiogenesis. © 1999 Cancer Research Campaign

Keywords: platelet-derived endothelial cell growth factor, angiogenesis, uterine cervical cancer

Full Text

The Full Text of this article is available as a PDF (186.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcari P., Martinelli R., Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 1984 Dec 11;12(23):9179–9189. doi: 10.1093/nar/12.23.9179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bremer G. L., Tiebosch A. T., van der Putten H. W., Schouten H. J., de Haan J., Arends J. W. Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):126–131. doi: 10.1016/s0002-9378(96)70384-8. [DOI] [PubMed] [Google Scholar]
  3. Burdett P. E., Kipps A. E., Whitehead P. H. A rapid technique for the detection of amylase isoenzymes using an enzyme sensitive "test-paper". Anal Biochem. 1976 May 7;72:315–319. doi: 10.1016/0003-2697(76)90536-4. [DOI] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Dinh T. V., Hannigan E. V., Smith E. R., Hove M. J., Chopra V., To T. Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol. 1996 May;87(5 Pt 1):751–754. doi: 10.1016/0029-7844(96)00039-7. [DOI] [PubMed] [Google Scholar]
  6. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature. 1980 Dec 11;288(5791):551–556. doi: 10.1038/288551a0. [DOI] [PubMed] [Google Scholar]
  7. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203. doi: 10.1016/s0065-230x(08)60946-x. [DOI] [PubMed] [Google Scholar]
  8. Fujimoto J., Hori M., Ichigo S., Tamaya T. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. Invasion Metastasis. 1995;15(5-6):203–210. [PubMed] [Google Scholar]
  9. Fujimoto J., Ichigo S., Sakaguchi H., Hirose R., Tamaya T. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers. Cancer Lett. 1998 Aug 14;130(1-2):115–120. doi: 10.1016/s0304-3835(98)00129-3. [DOI] [PubMed] [Google Scholar]
  10. Fujimoto J., Ichigo S., Sakaguchi H., Hirose R., Tamaya T. Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle. Mol Hum Reprod. 1998 May;4(5):509–513. doi: 10.1093/molehr/4.5.509. [DOI] [PubMed] [Google Scholar]
  11. Hagiwara K., Stenman G., Honda H., Sahlin P., Andersson A., Miyazono K., Heldin C. H., Ishikawa F., Takaku F. Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol. 1991 Apr;11(4):2125–2132. doi: 10.1128/mcb.11.4.2125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Haraguchi M., Miyadera K., Uemura K., Sumizawa T., Furukawa T., Yamada K., Akiyama S., Yamada Y. Angiogenic activity of enzymes. Nature. 1994 Mar 17;368(6468):198–198. doi: 10.1038/368198a0. [DOI] [PubMed] [Google Scholar]
  13. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 1990 Dec 6;348(6301):555–557. doi: 10.1038/348555a0. [DOI] [PubMed] [Google Scholar]
  14. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., Usuki K., Takaku F., Risau W., Heldin C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 1989 Apr 13;338(6216):557–562. doi: 10.1038/338557a0. [DOI] [PubMed] [Google Scholar]
  15. Kainz C., Speiser P., Wanner C., Obermair A., Tempfer C., Sliutz G., Reinthaller A., Breitenecker G. Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res. 1995 Jul-Aug;15(4):1549–1551. [PubMed] [Google Scholar]
  16. Macchiarini P., Fontanini G., Hardin M. J., Squartini F., Angeletti C. A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet. 1992 Jul 18;340(8812):145–146. doi: 10.1016/0140-6736(92)93217-b. [DOI] [PubMed] [Google Scholar]
  17. Maeda K., Chung Y. S., Ogawa Y., Takatsuka S., Kang S. M., Ogawa M., Sawada T., Onoda N., Kato Y., Sowa M. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer. 1996 Apr;73(8):884–888. doi: 10.1038/bjc.1996.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Miyadera K., Sumizawa T., Haraguchi M., Yoshida H., Konstanty W., Yamada Y., Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 1995 Apr 15;55(8):1687–1690. [PubMed] [Google Scholar]
  19. Nakano T., Oka K. Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer. Cancer. 1993 Oct 15;72(8):2401–2408. doi: 10.1002/1097-0142(19931015)72:8<2401::aid-cncr2820720818>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  20. Nishida M., Hino A., Mori K., Matsumoto T., Yoshikubo T., Ishitsuka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull. 1996 Nov;19(11):1407–1411. doi: 10.1248/bpb.19.1407. [DOI] [PubMed] [Google Scholar]
  21. O'Brien T., Cranston D., Fuggle S., Bicknell R., Harris A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 1995 Feb 1;55(3):510–513. [PubMed] [Google Scholar]
  22. Obermair A., Wanner C., Bilgi S., Speiser P., Kaider A., Reinthaller A., Leodolter S., Gitsch G. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol. 1998 Feb;178(2):314–319. doi: 10.1016/s0002-9378(98)80018-5. [DOI] [PubMed] [Google Scholar]
  23. Rutgers J. L., Mattox T. F., Vargas M. P. Angiogenesis in uterine cervical squamous cell carcinoma. Int J Gynecol Pathol. 1995 Apr;14(2):114–118. doi: 10.1097/00004347-199504000-00004. [DOI] [PubMed] [Google Scholar]
  24. Sawhney N., Hall P. A. Ki67--structure, function, and new antibodies. J Pathol. 1992 Oct;168(2):161–162. doi: 10.1002/path.1711680202. [DOI] [PubMed] [Google Scholar]
  25. Srivastava A., Laidler P., Davies R. P., Horgan K., Hughes L. E. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol. 1988 Nov;133(2):419–423. [PMC free article] [PubMed] [Google Scholar]
  26. Wakui S., Furusato M., Itoh T., Sasaki H., Akiyama A., Kinoshita I., Asano K., Tokuda T., Aizawa S., Ushigome S. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol. 1992 Nov;168(3):257–262. doi: 10.1002/path.1711680303. [DOI] [PubMed] [Google Scholar]
  27. Weidner N., Carroll P. R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993 Aug;143(2):401–409. [PMC free article] [PubMed] [Google Scholar]
  28. Yoshimura A., Kuwazuru Y., Furukawa T., Yoshida H., Yamada K., Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta. 1990 Apr 23;1034(1):107–113. doi: 10.1016/0304-4165(90)90160-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES